← All diseases
Cancer
Glioblastoma
Would you like to receive a message when there is new research about Glioblastoma? This is possible with an account. Create a free account or log in.
Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence
Read in plain language what each study is about? With Premium, above each publication you'll find one sentence explaining what was studied — and you'll be notified as soon as there is new research on Glioblastoma. View what Premium costs.
Publications and studies (2295)
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Does Gold-Silver Core-Shell Nanostructure with Alginate Coating Induce Apoptosis in Human Lymphoblastic Tumoral (Jurkat) Cell Line? (2023/07/01) ♡
- Evaluating Autoencoders for Dimensionality Reduction of MRI-derived Radiomics and Classification of Malignant Brain Tumors. (2023/07/01) ♡
- Non-invasive prediction of overall survival time for glioblastoma multiforme patients based on multimodal MRI radiomics. (2023/07/01) ♡
- Development and validation of an immunogenic cell death-related prognostic model, and landscape of the tumor immune microenvironment in glioblastoma. (2023/06/28) ♡
- Sanggenon C inhibits cell proliferation and induces apoptosis by regulating the MIB1/DAPK1 axis in glioblastoma. (2023/06/19) ♡
- Cdk4 Regulates Glioblastoma Cell Invasion and Stemness and Is Target of a Notch Inhibitor Plus Resveratrol Combined Treatment. (2023/06/13) ♡
- Multimodal In Vivo Tracking of Chimeric Antigen Receptor T Cells in Preclinical Glioblastoma Models. (2023/06/01) ♡
- CircRNA circ_POLA2 overexpression suppresses cell apoptosis by downregulating PTEN in glioblastoma. (2023/06/01) ♡
- Xihuang Pill-destabilized CD133/EGFR/Akt/mTOR cascade reduces stemness enrichment of glioblastoma via the down-regulation of SOX2. (2023/06/01) ♡
- An End-to-end In-Silico and In-Vitro Drug Repurposing Pipeline for Glioblastoma. (2023/06/01) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Tetra-O-methyl-nordihydroguaiaretic acid inhibits energy metabolism and synergistically induces anticancer effects with temozolomide on LN229 glioblastoma tumors implanted in mice while preventing obesity in normal mice that consume high-fat diets. (2023/05/25) ♡
- Retraction: Akt inhibition enhanced the growth inhibition effect of low-dose heavy-ion radiation via the PI3K/Akt/P53 signaling pathway in C6 glioblastoma cells. (2023/05/25) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Diet suppresses glioblastoma initiation in mice by maintaining quiescence of mutation-bearing neural stem cells. (2023/05/22) ♡
- Prognostic value of preoperative hematological markers in patients with glioblastoma multiforme and construction of random survival forest model. (2023/05/12) ♡
- Defining the role of mTOR pathway in the regulation of stem cells of glioblastoma. (2023/05/01) ♡
- Molecular Identity Changes of Tumor-Associated Macrophages and Microglia After Magnetic Resonance Imaging-Guided Focused Ultrasound-Induced Blood-Brain Barrier Opening in a Mouse Glioblastoma Model. (2023/05/01) ♡
- Angelica sinensis extract induces telomere dysfunction, cell cycle arrest, and mitochondria-mediated apoptosis in human glioblastoma cells. (2023/05/01) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. The effect of hydro alcoholic extract of Nigella sativa seeds on inflammatory mediators in C6 glioma cell line. (2023/05/01) ♡
- Exosomes released from U87 glioma cells treated with curcumin and/or temozolomide produce apoptosis in naive U87 cells. (2023/05/01) ♡
- Lysine catabolism reprograms tumour immunity through histone crotonylation. (2023/05/01) ♡
- Magnetic resonance imaging to assess the brain response to fasting in glioblastoma-bearing rats as a model of cancer anorexia. (2023/04/10) ♡
- Giant Somatosensory Evoked Potentials in Focal Epilepsy Secondary to Glioblastoma Multiforme. (2023/04/01) ♡
- Prognostic factors affecting outcome of multifocal or multicentric glioblastoma: A scoping review. (2023/04/01) ♡
- Oleic acid-bound FABP7 drives glioma cell proliferation through regulation of nuclear lipid droplet formation. (2023/04/01) ♡
- Metformin and simvastatin exert additive antitumour effects in glioblastoma via senescence-state: clinical and translational evidence. (2023/04/01) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Isolated Peptide from Spider Venom Modulates Dendritic Cells In Vitro: A Possible Application in Oncoimmunotherapy for Glioblastoma. (2023/03/27) ♡
- ELF4 is a critical component of a miRNA-transcription factor network and is a bridge regulator of glioblastoma receptor signaling and lipid dynamics. (2023/03/14) ♡
- Interaction of a Novel Alternatively Spliced Variant of HSD11B1L with Parkin Enhances the Carcinogenesis Potential of Glioblastoma: Peiminine Interferes with This Interaction. (2023/03/14) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Ketogenic therapies for glioblastoma: Understanding the limitations in transitioning from mice to patients. (2023/03/07) ♡
- Cancer Stem Cell Markers - CD133 and CD44 - in Paediatric Solid Tumours: A Study of Immunophenotypic Expression and Correlation with Clinicopathological Parameters. (2023/03/01) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Commentary: Complementary and Alternative Medicine for Gliomas: Systematic Review and Critical Appraisal of Current Literature. (2023/03/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Cellular Conversations in Glioblastoma Progression, Diagnosis and Treatment. (2023/03/01) ♡
- Analysis of bioactive compounds using LC-ESI-MS/MS, cytotoxic, antimicrobial effects, and enzyme activities from Cyclotrichium origanifolium. (2023/03/01) ♡
- Mesenchymal Stem Cell-mediated Image-guided Sodium Iodide Symporter (NIS) Gene Therapy Improves Survival of Glioblastoma-bearing Mice. (2023/03/01) ♡
- Systematic reviewiAll research on one question is searched according to fixed rules and compared side by side, so that no studies with poor outcomes are missed. Towards standardization of the parameters for opening the blood-brain barrier with focused ultrasound to treat glioblastoma multiforme: A systematic review of the devices, animal models, and therapeutic compounds used in rodent tumor models. (2023/02/16) ♡
- Selective and brain-penetrant lanosterol synthase inhibitors target glioma stem-like cells by inducing 24(S),25-epoxycholesterol production. (2023/02/16) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Prognostic value of prognostic nutritional index score and controlling nutritional status score in patients with glioblastoma: A comprehensive meta-analysis. (2023/02/16) ♡
- Brain radiotoxicity-related 15CAcBRT gene expression signature predicts survival prognosis of glioblastoma patients. (2023/02/14) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Biological Activities of Ruthenium NHC Complexes: An Update. (2023/02/09) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Three-Dimensional (3D) in vitro cell culture protocols to enhance glioblastoma research. (2023/02/08) ♡
- Systematic study of tissue factor expression in solid tumors. (2023/02/01) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. The in vitro and in vivo anticancer activities of Antrodia salmonea through inhibition of metastasis and induction of ROS-mediated apoptotic and autophagic cell death in human glioblastoma cells. (2023/02/01) ♡
- Prognostic and predictive factors of secondary gliosarcoma: A single-institution series of 18 cases combined with 89 cases from literature. (2023/01/31) ♡
- Development of a novel angiogenesis-related lncRNA signature to predict the prognosis and immunotherapy of glioblastoma multiforme. (2023/01/30) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Pleiotropic effects of the COX-2/PGE2 axis in the glioblastoma tumor microenvironment. (2023/01/26) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. TRIM8: a double-edged sword in glioblastoma with the power to heal or hurt. (2023/01/23) ♡
- Eighteen years' experience with tumor treating fields in the treatment of newly diagnosed glioblastoma. (2023/01/19) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Editorial: Insights in neuro-oncology and neurosurgical oncology: 2021. (2023/01/17) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Glioblastoma and the search for non-hypothesis driven combination therapeutics in academia. (2023/01/17) ♡
- DGKB mediates radioresistance by regulating DGAT1-dependent lipotoxicity in glioblastoma. (2023/01/17) ♡
codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.